The liver can create a uniquely favorable milieu for early colonization by metastatic pancreatic cancer cells. A study now highlights mechanisms — such as neutrophil extracellular traps, or NETs — that drive this process; this could inform strategies for intercepting metastasis and improving survival.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Groot, V. P. et al. Ann. Surg. 267, 936–945 (2018).
Bojmar, L. et al. Nat. Med. https://doi.org/10.1038/s41591-024-03075-7 (2024).
Lee, J. W. et al. Nature 567, 249–252 (2019).
Costa-Silva, B. et al. Nat. Cell Biol. 17, 816–826 (2015).
Huby, T. & Gautier, E. L. Nat. Rev. Immunol. 22, 429–443 (2022).
Wang, G. Nature 618, 374–382 (2023).
Xue, R. et al. Nature 612, 141–147 (2022).
Adrover, J. M., McDowell, S. A. C., He, X. Y., Quail, D. F. & Egeblad, M. Cancer Cell 41, 505–526 (2023).
Yang, L. et al. Nature 583, 133–138 (2020).
Zhang, Y. et al. J. Exp. Med. 217, e210190354 (2020).
Mousset, A., Bellone, L., Gaggioli, C. & Albrengues, J. Trends Cancer https://doi.org/10.1016/j.trecan.2024.03.007 (2024).
Acknowledgements
We thank E. Y. Faraoni for her valuable comments on this article.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
F.M. is a scientific advisory board member at Neologics Bio. A.M. is a consultant for Tezcat Biosciences and is named on a patent that has been licensed to ThriveEarlier Detection, an Exact Sciences Company. L.L declares no competing interests.
Rights and permissions
About this article
Cite this article
Li, L., McAllister, F. & Maitra, A. The liver casts a wide NET for metastatic pancreatic cancer. Nat Med 30, 2125–2126 (2024). https://doi.org/10.1038/s41591-024-03112-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-024-03112-5